Posts by: Daniela Semedo, PhD

Daniela Semedo, PhD

Daniela holds a PhD in Clinical Psychology from The University of Edinburgh, United Kingdom, a MSc in Health Psychology and a BSc in Clinical Psychology. Her work has been focused on vulnerability to psychopathology and early identification and intervention in psychosis.

May 25, 2015May 26, 2015

Novartis Announces Extended Progression-free Survival in Phase III Afinitor Trial For Advanced Lung Neuroendocrine Tumors

Lung Cancer, News

Novartis recently announced that RADIANT-4, a prospective, double-blind, randomized, Phase III study that evaluated the efficacy and safety of Afinitor (everolimus) tablets used together with best supportive care, has met its ... Read more

May 25, 2015November 6, 2015

Serendex Pharmaceuticals, Novoenzymes’ Therapy For Bronchiectasis, Molgradex, to Begin Clinical Trials

Bronchiectasis, News

Denmark-based Serendex Pharmaceuticals, a company developing drugs to treat severe respiratory conditions, recently announced the initiation of Phase I clinical trials for their drug candidate Molgradex, based on their Granulocyte Macrophage ... Read more

May 22, 2015November 9, 2015

Novartis Presents Results for Compound That Improves COPD Lung Function at ATS 2015

COPD, News

Novartis recently announced the results of the EXPEDITION trial, a phase III study that is evaluating the efficacy of QVA149 (indacaterol/glycopyrronium) in patients with moderate-to-severe chronic obstructive pulmonary disease (COPD). ... Read more

May 21, 2015November 5, 2015

Need For Improved Monitoring of Pulmonary Hypertension After Pulmonary Embolism Highlighted At 2015 ATS Conference

News, Pulmonary Hypertension

In a study recently presented during the 2015 Annual International Conference of the American Thoracic Society (ATS), researchers found that the incidence of pulmonary hypertension (PH) among patients who experienced pulmonary ... Read more

May 20, 2015November 9, 2015

Predictors of Exacerbations Studied in Chronic Obstructive Pulmonary Disease

COPD, News

In a study recently presented during the 2015 American Thoracic Society International Conference , researchers from Brigham and Women’s Hospital in Boston found an association between exacerbations chronic obstructive pulmonary disease ... Read more

May 19, 2015November 5, 2015

Bayer Presents New Research on Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension at 2015 ATS Annual Conference

News, Pulmonary Hypertension

During the 2015 Annual International Conference of the American Thoracic Society (ATS), Bayer HealthCare is presenting recent research on chronic thromboembolic pulmonary hypertension (CTEPH) and pulmonary arterial hypertension (PAH). The conference is taking ... Read more

May 18, 2015November 9, 2015

Anemia Reduces Exercise Capacity, Negatively Impacts Quality of Life in COPD Patients

COPD, News

Findings from a recent study published in the journal BMC Pulmonary Medicine show that anemia reduces exercise capacity and negatively impacts quality of life in patients with COPD. Chronic obstructive ... Read more

May 15, 2015May 15, 2015

Veracyte Publishes Results of Percepta Bronchial Genomic Classifier for Lung Cancer

Lung Cancer, News

Veracyte, a biotech company working in the field of molecular cytology with a focus on genomic solutions that resolve diagnostic ambiguity, recently announced the publication of a study on the journal BMC ... Read more

May 13, 2015November 5, 2015

Daily Physical Activity Associated With Aerobic Capacity in Adults With Cystic Fibrosis

Cystic Fibrosis, News

Results from a recent study published in the journal BMC Pulmonary Medicine indicate that in adult patients with Cystic Fibrosis, daily physical activity is associated with aerobic capacity. In cystic fibrosis ... Read more

May 13, 2015November 9, 2015

Draft Opinion released by the European Medicines Agency on Two Patient-Reported Outcome (PRO) tools for COPD treatments evaluation

COPD, News

Evidera, a biotechnology company that provides solutions based on current evidence for the healthcare industry, recently announced the release of a draft qualification opinion of the European Medicines Agency’s (EMA) regarding two ... Read more